Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.

Published in: European heart journal (2021)

Keyphrases

meta analyses
systematic review
randomized controlled trial
left ventricular
percutaneous coronary intervention
coronary artery bypass grafting
coronary artery disease
heart failure
acute coronary syndrome